I'm an Optometrist. Here's Why I Took My Own Mother Off Her Old Eye Vitamin.

Apr 14, 202611 min readMedically reviewed

This article is produced by Klaris

Dr. Elena Markovic, MD
Medically reviewed by
Dr. Elena Markovic, MD
Neuro-ophthalmology, 20+ years
Reviewed June 2026

My mother stopped reading in the evening.

She never announced it. The book sat on the arm of her chair for about a month, then it went back on the shelf, and neither of us said anything about it.

Then it was the drive home. She started asking me to collect her after six. Then she stopped asking to go anywhere after dark at all.

She is 68. She has been taking the same eye vitamin since 2011.

For fifteen years, I recommended it to her. I recommended it to thousands of patients. It was the default. The one every pharmacist pointed to. The one printed on the take-home sheet at every optometry office in the country.

I am an eye doctor. I have spent twenty years telling other people's families what to watch for in their parents. It took me almost two years to turn over the bottle sitting on my own mother's counter.

The formula on the back had not changed in twelve years.

Last spring, I took it off her counter.

Optometrist examining an older patient with a slit lamp
Stock image, for illustrative purposes only.

I replaced it with something most of my patients have never heard of. Not because the old formula was dangerous. Not because she had a bad reaction. But because, quietly, the science moved past it, and the shelf didn't.

If you, or someone you take care of, has been taking an AREDS2-based eye vitamin for a year or more, this is the conversation I wish I had with every one of my patients at their next visit.

The short version
  • The third carotenoid
  • The focus muscle
  • The optic nerve's blood supply
Close-up of a mature adult's eye
My mother, like millions of adults over 60, has trusted the same eye vitamin for over a decade.

Most of the patients I see are over 55. Many come in with an inherited risk of macular degeneration, or with early signs of their own.

The standard recommendation for this group has been the AREDS2 formula, published in 2013 by the U.S. National Eye Institute. It was a real study. It was well-designed.

And it showed, for the first time, that a specific combination of nutrients could slow the progression of age-related macular degeneration.

The original formula was simple: Vitamin C, Vitamin E, Lutein, Zeaxanthin, Zinc, and Copper. That is almost exactly what every eye vitamin on the pharmacy shelf still contains today.

2013 was a long time ago. The research has not stood still.

Medical professional recording clinical data on a clipboard
A decade of new clinical research has reshaped what an effective eye-health formula should contain.

2.What changed after 2013

1. The third carotenoid

The back of your eye has a small yellow patch called the macula. It is about the size of a dime.

It is the only part of your eye capable of sharp, detailed vision. It is what lets you read a menu, recognize a face across a room, or see the difference between a 3 and an 8 on a car dashboard.

Anatomical diagram of the human eye showing the macula, fovea, and other structures
The macula and fovea are where your sharpest vision lives, and where age-related decline begins first.

That yellow color comes from three plant pigments: lutein, zeaxanthin, and meso-zeaxanthin. Together they form your eye's internal blue-light filter.

The AREDS2 formula includes the first two. It does not include meso-zeaxanthin, because it was not a standard supplement ingredient when that trial was designed.

But meso-zeaxanthin is the dominant pigment at the very center of your macula, the small spot called the fovea.

The fovea is responsible for your sharpest vision. It is also the part of the retina that degenerates first.

If your current eye vitamin does not list meso-zeaxanthin, it is missing the pigment most concentrated in the part of your retina most at risk.

2. The focus muscle

Look at this page. Now look across the room. Now look back at this page. Every time you changed distance, a small ring of muscle inside your eye, called the ciliary muscle, squeezed and relaxed to reshape your lens.

After eight hours at a screen, that muscle goes into a kind of partial cramp. Your eyes feel heavy. Your vision blurs when you look up from your book. AREDS2 does nothing for this muscle. It was not designed to.

Two-panel diagram of the eye's focusing ring muscle, squeezed during close-up use and relaxed when looking far away
The focusing ring squeezes for near work and relaxes for distance. Hours of close-up keep it squeezed. Simplified illustration.

Astaxanthin, a deep-red pigment from a microalga, concentrates directly in the ciliary muscle. Multiple clinical trials have shown that astaxanthin reduces eye strain, improves focus endurance, and shortens the time it takes your eyes to recover after sustained near work. Most eye vitamins on the shelf include none.

3. The optic nerve's blood supply

The optic nerve is the cable that carries vision from your eye to your brain. It runs on a network of very small blood vessels.

A large analysis from the Women's Antioxidant and Folic Acid Cardiovascular Study followed women for seven years.

The group taking a combination of folic acid, vitamin B6, and vitamin B12 had a lower incidence of age-related macular degeneration than the placebo group. (That trial used higher B-vitamin doses than most supplements contain.)

Most eye vitamins contain no B-vitamins at all.

of adults
The ones that do often include them in inactive forms, which matters because about a third of adults have a common genetic variant (MTHFR) that makes converting inactive folate into its active form much less efficient.
Diagram of the optic nerve running from the eye to the brain with small blood vessels along it
The optic nerve carries vision from the eye to the brain and runs on a network of very small vessels. Simplified illustration.

3.The three things missing from almost every AREDS2 bottle

Put those three findings side by side, and you get a clear list:

1
Meso-zeaxanthinthe pigment at the center of the retina.
2
Astaxanthinfor the ciliary focus muscle.
3
Active-form B-vitaminsfor the optic nerve's blood supply.
Two things a label hides

There are two other issues that are harder to see on a label.The first is zinc form: the original AREDS2 trial used zinc oxide, which is cheap and poorly absorbed.The second is beta-carotene: it was shown to increase lung cancer risk in current and former smokers, and AREDS2 removed it in 2013, yet some general-use eye vitamins still contain it.

I came across Klaris in 2025. I read the label first, the way I read every label. I wanted to see if the company had built the formula that the research since 2013 actually pointed to, or if it was another AREDS2 copy in a different bottle.

It was not a copy.

Klaris is what I would build if I sat down and wrote the ideal modern eye-vitamin spec.

Overview of the eleven ingredients in the Klaris Supplement
The Klaris formula combines eleven targeted ingredients designed around the research that came after AREDS2.
What is in the Klaris Supplement
Lutein10 mg (from marigold)
Zeaxanthin2 mg (from marigold)
Meso-zeaxanthin10 mg
Astaxanthin4 mg (from red algae)
Vitamin C250 mg
Vitamin E134 mg
Active Vitamin B62 mg
Methyl folate400 mcg DFE
Methylcobalamin (B12)250 mcg
Zinc citrate25 mg
Copper citrate2 mg
What is actually in it

Eleven ingredients. No beta-carotene. No synthetic fillers. Plant-based throughout. Produced in an FDA-registered, GMP-certified facility.

What she was taking before

For my mother, this consolidated what she had been taking across three bottles, her old eye vitamin, a B-complex, and a separate antioxidant, into one daily habit.

See the Klaris Supplement

4.What to expect: a realistic timeline

A realistic timeline showing benefits from Day 1 to Month 6
What patients typically notice, from the first week through six months of consistent use.

These are general patterns from studies and clinical experience; individual results vary, and a supplement is not a treatment.

I tell every patient the same thing when they start a new formula. This is not a pain reliever. You will not feel an effect on day one. Macular pigment rebuilds on a tissue timescale.

1
Days 1 to 7Active-form B-vitamins begin absorbing immediately. Astaxanthin starts accumulating in ciliary muscle tissue.
2
Weeks 1 to 3The most common early change is reduced screen fatigue. Patients report that the 3 PM burn softens.
3
Months 1 to 2Macular pigment density begins to measurably rebuild.
4
Months 3 to 4Patients report small but real improvements in contrast. Menus in dim restaurants get easier. Night driving feels less stressful.
5
Months 5 to 6The full protective effect settles in. Macular pigment density is near its new baseline.

"I didn't realize my eyes were getting tired that early in the day until they stopped." That is the most common thing patients say to me after sixty to ninety days on Klaris Supplement.

5.The bottom line

Visual comparison of the standard AREDS2 formula versus the Klaris Vision Support formula
The standard AREDS2 formula side by side with the modern Klaris Vision Support formula.

I am not writing this because I have a grudge against the AREDS2 formula. It was a genuine breakthrough. I used it for fifteen years.

I am writing this because the research has kept moving, and most of what you can buy at the pharmacy has not. The right update is not complicated. It is three ingredients, one cleaner mineral form, and the removal of one old one. That is exactly what the Klaris Supplement is.

My mother has been on it for a year. If you want to make the same switch I made for her, this is the formula I recommend.

Elderly mother and her adult daughter walking arm in arm along a sunlit garden path

Rated 4.8 / 5 based on 1,247+ verified reviews


This article is for general educational purposes and is not medical advice. If you have a diagnosed eye condition or are on medications, please discuss any new supplement with your eye care professional. These statements have not been evaluated by the Food and Drug Administration. Klaris is not intended to diagnose, treat, cure, or prevent any disease.

References

  1. Age-Related Eye Disease Study 2 (AREDS2) Research Group. JAMA. 2013.
  2. Nolan JM, et al. Macular pigment and visual performance in subjects with age-related macular degeneration. Curr Eye Res. 2016.
  3. Hammond BR, et al. The effects of macular pigment on visual performance. Vision Res. 2014.
  4. Piermarocchi S, et al. Carotenoids in age-related maculopathy: the CARMIS study. Eur J Ophthalmol. 2012.
  5. Christen WG, et al. Folic acid, B6, and B12 in combination and age-related macular degeneration. Arch Intern Med. 2009.

Frequently Asked Questions

Still have questions? Contact us.

About the author

Dr. Elena Markovic, MD, neuro-ophthalmologist and Klaris medical reviewer

Dr. Elena Markovic, MD

Neuro-ophthalmology, 20+ years in clinical practice

Dr. Markovic reviews every Klaris article for medical accuracy. Her clinical focus is age-related vision change, macular pigment and the nutrition behind both. Read Dr. Markovic’s full profile.

Dr. Elena Markovic examining a patient at the slit lamp and reviewing chart notes
Dr. Markovic specialises in neuro-ophthalmology, diagnosing and managing complex conditions of the optic nerve, brain and eye movement pathways.